Home | About Jay Hochman -Pediatric Gastroenterology Blog | Archives
January 9, 2017 7:00 am
Last week, I posted an blog referencing new guidelines for peanut introduction. A more detailed explanation of these guidelines: New Guidelines: Early Introduction of Peanut to Prevent Peanut Allergy from David Stukus (Thanks to Kipp Ellsworth for sharing this information)
_________________
A recent study (PL Valentino et al. JPGN 2016; 63: 603-09) follows “the largest reported pediatric PSC cohort” to determine the natural history.
Study characteristics:
This retrospective study followed 120 children (1-21 yrs) with a median age of 14 years. 27% had autoimmune sclerosing cholangitis (ASC), 63% had PSC; 24% (n=29) of entire cohort had exclusive small duct PSC. Median followup was 3.7 years.
Key findings:
The authors speculate that one reason for milder PSC-IBD disease could relate to the fact that IBD patients undergo frequent chemistries. In those without IBD, subacute PSC could be present for a much longer period before detection. The authors note that PSC in children presents as a milder disease with only 10% having cirrhossi compared with 30% in studies with adult patients.
My take: We have a lot to learn about PSC including which patients are likely to develop clinically significant liver disease and whether most patients benefit from treatment.
Related blog post: Should we care about subclinical PSC? (This post has links to others related to PSC)
Posted by gutsandgrowth
Categories: inflammatory bowel disease, Pediatric Gastroenterology Liver Disease
Tags: peanut guideline, primary sclerosing cholangitis
Mobile Site | Full Site
Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.
[…] PSC/Prevention Guidelines from David Stutkus GutsandGrowth […]
By Peanut Allergy Prevention Guidelines | gutsandgrowth on January 26, 2017 at 9:23 am